JP2024516174A5 - - Google Patents
Info
- Publication number
- JP2024516174A5 JP2024516174A5 JP2023564585A JP2023564585A JP2024516174A5 JP 2024516174 A5 JP2024516174 A5 JP 2024516174A5 JP 2023564585 A JP2023564585 A JP 2023564585A JP 2023564585 A JP2023564585 A JP 2023564585A JP 2024516174 A5 JP2024516174 A5 JP 2024516174A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163179053P | 2021-04-23 | 2021-04-23 | |
| US63/179,053 | 2021-04-23 | ||
| US202263308376P | 2022-02-09 | 2022-02-09 | |
| US63/308,376 | 2022-02-09 | ||
| PCT/US2022/026186 WO2022226408A1 (en) | 2021-04-23 | 2022-04-25 | Novel ergolines and methods of treating mood disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024516174A JP2024516174A (ja) | 2024-04-12 |
| JPWO2022226408A5 JPWO2022226408A5 (https=) | 2025-05-09 |
| JP2024516174A5 true JP2024516174A5 (https=) | 2025-05-09 |
Family
ID=81648213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564585A Pending JP2024516174A (ja) | 2021-04-23 | 2022-04-25 | 新規エルゴリン及び気分障害を処置する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240368151A1 (https=) |
| EP (1) | EP4326718A1 (https=) |
| JP (1) | JP2024516174A (https=) |
| KR (1) | KR20240019091A (https=) |
| AU (1) | AU2022262659A1 (https=) |
| BR (1) | BR112023021970A2 (https=) |
| CA (1) | CA3223210A1 (https=) |
| IL (1) | IL307880A (https=) |
| MX (1) | MX2023012447A (https=) |
| WO (1) | WO2022226408A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230116703A1 (en) * | 2021-04-23 | 2023-04-13 | Gilgamesh Pharmaceuticals, Inc. | Novel ergolines and methods of treating mood disorders |
| CN117355302A (zh) | 2021-04-30 | 2024-01-05 | 思维医学股份有限公司 | Lsd盐晶体形式 |
| JP2024529727A (ja) | 2021-08-19 | 2024-08-08 | マインド メディシン， インコーポレイテッド | 治療適用のためのｄ－リゼルグ酸ジエチルアミドの凍結乾燥された口腔内崩壊錠製剤 |
| JP2025525375A (ja) * | 2022-06-20 | 2025-08-05 | マインド メディシン， インコーポレイテッド | 修飾ｌｓｄ様作用を有するリゼルグ酸誘導体 |
| EP4630418B1 (en) * | 2022-12-31 | 2026-03-18 | Ceruvia Lifesciences LLC | Salts of 2-bromolysergic acid diethylamide |
| EP4704846A2 (en) * | 2023-05-04 | 2026-03-11 | Gilgamesh Pharmaceuticals, Inc. | Novel ergolines and methods of treating mood disorders |
| WO2025194238A1 (en) * | 2024-03-22 | 2025-09-25 | Blife Therapeutics Inc. | 2-bromo-lsd salts and polymorphs |
| WO2025235800A1 (en) | 2024-05-08 | 2025-11-13 | Cy Biopharma Ag | Ergoline derivatives and uses thereof |
| WO2025235784A2 (en) * | 2024-05-08 | 2025-11-13 | Cy Biopharma Ag | Ergoline derivatives and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2438259A (en) * | 1948-03-23 | D-lysergic acid diethyl amide | ||
| CN1087725C (zh) * | 1994-03-25 | 2002-07-17 | 同位素技术有限公司 | 用氘代方法增强药物效果 |
| EP4219498A1 (en) * | 2019-03-07 | 2023-08-02 | Arbormentis LLC | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations |
| US20230295106A1 (en) * | 2019-10-14 | 2023-09-21 | The Regents Of The University Of California | Ergoline-like compounds for promoting neural plasticity |
| EP4178956A2 (en) * | 2020-07-07 | 2023-05-17 | COMPASS Pathfinder Limited | Improved method for the production of lysergic acid diethylamide (lsd) and novel derivatives thereof |
-
2022
- 2022-04-25 KR KR1020237040483A patent/KR20240019091A/ko active Pending
- 2022-04-25 EP EP22723308.7A patent/EP4326718A1/en active Pending
- 2022-04-25 IL IL307880A patent/IL307880A/en unknown
- 2022-04-25 BR BR112023021970A patent/BR112023021970A2/pt unknown
- 2022-04-25 JP JP2023564585A patent/JP2024516174A/ja active Pending
- 2022-04-25 WO PCT/US2022/026186 patent/WO2022226408A1/en not_active Ceased
- 2022-04-25 US US18/287,980 patent/US20240368151A1/en active Pending
- 2022-04-25 AU AU2022262659A patent/AU2022262659A1/en active Pending
- 2022-04-25 MX MX2023012447A patent/MX2023012447A/es unknown
- 2022-04-25 CA CA3223210A patent/CA3223210A1/en active Pending